Next Article in Journal
Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes
Previous Article in Journal
Oxidative and Antioxidative Status Expressed as OSI Index and GSH/GSSG Ratio in Children with Bone Tumors after Anticancer Therapy Completion
 
 
Article

Article Versions Notes

J. Clin. Med. 2022, 11(6), 1664; https://doi.org/10.3390/jcm11061664
Action Date Notes Link
article xml file uploaded 17 March 2022 07:41 CET Original file -
article xml uploaded. 17 March 2022 07:41 CET Update -
article pdf uploaded. 17 March 2022 07:41 CET Version of Record -
article html file updated 17 March 2022 07:42 CET Original file -
article xml file uploaded 17 March 2022 09:21 CET Update -
article xml uploaded. 17 March 2022 09:21 CET Update https://www.mdpi.com/2077-0383/11/6/1664/xml
article pdf uploaded. 17 March 2022 09:21 CET Updated version of record https://www.mdpi.com/2077-0383/11/6/1664/pdf
article html file updated 17 March 2022 09:23 CET Update -
article html file updated 1 August 2022 06:05 CEST Update https://www.mdpi.com/2077-0383/11/6/1664/html
Back to TopTop